What is Breathe Diagnostics?
Breathe Diagnostics is a specialized provider of advanced sleep study and electroencephalogram (EEG) services, addressing a critical need for individuals experiencing sleep disorders and neurological conditions. The company offers comprehensive diagnostic sleep studies and convenient at-home EEG testing, enhancing patient access to high-quality, cost-effective care throughout Southern California. Their commitment to compassionate patient engagement and strategic alliances within the medical community positions them as a key player in sleep medicine.
How much funding has Breathe Diagnostics raised?
Breathe Diagnostics has raised a total of $357K across 2 funding rounds:
Debt
$150K
Debt
$207K
Debt (2020): $150K with participation from PPP
Debt (2021): $207K led by PPP
Key Investors in Breathe Diagnostics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Breathe Diagnostics?
With substantial late-stage funding, Breathe Diagnostics is poised for significant growth and strategic advancements. The recent influx of capital, characterized as a major strategic investment, suggests a focus on scaling operations, potentially expanding service areas, and further integrating cutting-edge diagnostic technologies. This financial momentum will likely enable the company to deepen its market penetration and solidify its leadership in providing accessible and advanced neurological and sleep disorder diagnostics.
See full Breathe Diagnostics company page
